Corporate News Cassava Sciences GAAP EPS of -$0.57 beats by $0.09 by Contributor since / Followers 1 month ago Cassava Sciences press release (NASDAQ:SAVA): Q4 GAAP EPS of -$0.57 beats by $0.09. At December 31, 2024, cash and cash equivalents were $128.6 million, with no debt. Tags: SAVA Continue Reading Previous Occidental to exercise warrants at temporarily reduced price for proceeds of up to $1.6BNext Broadcom, Marvell, Credo could ‘reenergize’ AI trade, BofA says Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Δ